Envoy Medical (COCH) vs. Its Competitors Head-To-Head Contrast

Envoy Medical (NASDAQ:COCH) is one of 51 public companies in the “Surgical appliances & supplies” industry, but how does it contrast to its competitors? We will compare Envoy Medical to related companies based on the strength of its dividends, institutional ownership, profitability, earnings, risk, valuation and analyst recommendations.

Analyst Recommendations

This is a summary of current recommendations and price targets for Envoy Medical and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
Envoy Medical Competitors	405	1428	2555	117	2.53

Envoy Medical currently has a consensus price target of $9.13, indicating a potential upside of 500.33%. As a group, “Surgical appliances & supplies” companies have a potential upside of 22.93%. Given Envoy Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than its competitors.

Institutional and Insider Ownership

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 45.5% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 60.5% of Envoy Medical shares are owned by insiders. Comparatively, 10.1% of shares of all “Surgical appliances & supplies” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Envoy Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-7,607.55%	N/A	-262.28%
Envoy Medical Competitors	-169.94%	-74.14%	-20.85%

Volatility & Risk

Envoy Medical has a beta of 2.33, indicating that its stock price is 133% more volatile than the S&P 500. Comparatively, Envoy Medical’s competitors have a beta of 1.25, indicating that their average stock price is 25% more volatile than the S&P 500.

Valuation and Earnings

This table compares Envoy Medical and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Envoy Medical	$212,000.00	-$29.91 million	-1.10
Envoy Medical Competitors	$1.42 billion	$234.66 million	20.40

Envoy Medical’s competitors have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Envoy Medical competitors beat Envoy Medical on 7 of the 13 factors compared.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.